戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                             Reduction in donor-specific antibody (DSA) has been associate
2                                                             Reduction in neuroinflammation by using samples from post-FMT
3 lbus) to MeHg also caused early breeding failure and a ~20% reduction in breeding numbers at environmentally relevant exp
4 umbers under exposure levels otherwise associated with <20% reduction in post-egg-laying breeding success.
5 omposite outcome (time to first occurrence of either: >=50% reduction in estimated glomerular filtration rate (eGFR), end
6  (WHO) hepatitis C virus (HCV) elimination target of an 80% reduction in incidence by 2030 may be reachable ahead of time
7  in feedback correction in the middle of the movement and a reduction in motor noise near the target.
8                     SUV4-20 inhibition was accompanied by a reduction in H4K20me2 and H4K20me3 and an increase in H4K20me
9                              Treatment was accompanied by a reduction in the angioedema attack rate.
10                                     HS2ST1 variants cause a reduction in HS2ST1 mRNA and decreased or absent heparan sulf
11                                    This article describes a reduction in childhood vaccinations during the COVID-19 pande
12 d that, following the intervention, individuals displayed a reduction in coupling from ipsilesional M1 to contralesional
13             Accordingly, AAV9-CRISPR treatment results in a reduction in the percent of proviral DNA in blood and tissues
14 of EAE that may contribute to these phenotypes, including a reduction in adult locomotor activity, alterations in viscera
15 s are rapidly incorporated into membrane lipids, inducing a reduction in membrane packing.
16             Of the 23 nucleoporins evaluated, we observed a reduction in a subset of 8, including key components of the n
17                                    MMP1 expression led to a reduction in collagen 1A1 levels.
18 nuation of NNRTI-based ART, introducing DTG would lead to a reduction in NNRTI PDR in all scenarios if ART initiators are
19 thermore, we found that the rd10 mutation in Pde6b led to a reduction in the assembled PDE6alphabetagamma2 complex, which
20 ther hand, within the cART suppressed macaques, there was a reduction in cell-associated DNA load, intact proviral DNA le
21 r enasidenib, leading to improved quality of life without a reduction in AML disease burden.
22  amygdala and hypothalamus whilst producing a corresponding reduction in ethanol intake in KO mice.
23                                                        DNAN reduction in the presence of RDX was evaluated in abiotic exp
24  fewer cases per 100 000 women-years, and an 85% or greater reduction in incidence.
25 ed throughout the ATI lifespan through a potent homeostatic reduction in presynaptic neurotransmitter release.
26  in contact with electrodes that exhibit a pressure-induced reduction in electrical conductivity-and the presence of a co
27                     The program was associated with initial reduction in 30-day readmission (-9.8%, P=0.0002) and 30-day
28 ndrome, stroke, or coronary revascularisation) per 1 mmol/L reduction in LDL cholesterol.
29 nd EC emissions from mobile sources contributed the largest reduction in particle-related mortality rates respectively.
30 reduced levels of MUC5AC protein expression, they showed no reduction in the degree of mucus obstruction, MUC5B protein e
31 , orc1a, ppd1, and mcm4 mutants showed different degrees of reduction in rosette size, thus confirming the role of these
32                              There is anecdotal evidence of reduction in organ donation and transplantation activity acro
33  When 25% participated (n = 101), there was a 9.1% relative reduction in incident carriers (20.4% and 1.6% in participati
34 onparticipating facilities, respectively) and 2.8% relative reduction in prevalence.
35 .0% point (95% CI: -18.1, -3.8; P < 0.01) adjusted relative reduction in anemia prevalence and a mean +0.26-g/dL (95% CI:
36 lmonary Disease Treatment) trial demonstrated a significant reduction in all-cause mortality (ACM) risk with fluticasone
37              The ancillary advantage would be a significant reduction in India's future power sector related emissions of
38 and a murine colitis model expressing hPXR by a significant reduction in inflammation biomarkers.
39    Furthermore, treatment was associated with a significant reduction in NT-proBNP and cTnI, suggesting improvement in my
40 o deaths or device-related adverse events and a significant reduction in right ventricular to left ventricular diameter r
41                                    We also observed a small reduction in activity magnitude during the bimanual loads for
42         Patients with UEL appear to have a more substantial reduction in limb volume differential compared to LEL patient
43  that BRCA2 tumor suppressor function tolerates substantial reduction in full-length transcripts, helping to determine th
44 ctivity is linked to T-bet in Ag-expCD4(+) T cells but that reduction in mTOR activity may not directly underpin Ag-expTh
45                                                         The reduction in An and gs after anthesis in both water condition
46                             PFOS exposure recapitulated the reduction in length but could not predict effects on developm
47 of NRF2 levels after SARRAH silencing partially rescues the reduction in cell viability.
48 rations (doped into the nebulized aerosol) reveals that the reduction in viable PRCV is primarily due to UV-C based inact
49 itor-1, was depressed by exposure to high glucose, with the reduction in nitric oxide production being the most notable.
50       Taking excess mortality risk into consideration, this reduction in the number of deaths is projected to produce a g